Michael G. Atieh

Michael G. Atieh, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Chubb Ltd, IVERIC bio, Inc. and Oyster Point Pharma, Inc. Over a trading history stretching from 2 January 2016 to 21 May 2026, the count stands at 22 filings.

No open-market purchase appears, only 11 sales worth €1.2M. The totals exclude 5 filings filed without an amount. Outside the open market, there are 9 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.

The latest filing, published on 26 May 2026, reports a share grant of €55k in Chubb Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.